Skip to main content
2024 Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Suneet Shukla, PhD (he/him/his)

Director, Clinical Pharmacology
Boehringer Ingelheim Pharmaceuticals Inc

Dr Suneet Shukla is a Director (Clinical Pharmacology) at Boehringer Ingelheim Pharmaceuticals, USA where he leads Clinical Pharmacology programs in oncology, inflammation, and cardio renal metabolism therapeutic areas for both large and small molecules.
Dr Suneet Shukla is a pharmacist by educational training with a Ph.D. in molecular pharmacology, studying drug transporters, and their role in fungal infections, cancer drug resistance, and altering ADME-toxicity of drugs. After graduation, he continued to pursue his research interest in drug transporters for over 10 years at the National Cancer Institute (NCI), NIH where he completed his postdoctoral training and was later appointed Staff Scientist. He then joined US Food and Drug Administration and has worked in the Offices of Generic Drugs and Clinical Pharmacology and also acted as ophthalmology lead where his responsibilities included the review of INDs, NDAs, ANDAs, and other regulatory submissions from a biopharmaceutics, bioequivalence and clinical pharmacology perspective.

Suneet has published several highly cited research and review articles, received patents, and awards from NIH and FDA. He has served on panels evaluating research grants submitted to NIH and FDA, mentored several undergraduate, graduate, and post-doctoral trainees, and has served as the lead instructor of the medical pharmacology course at the Foundation for Advanced Education in the Sciences (FAES) Graduate School, NIH.

Disclosure information not submitted.

Presentation(s):